Methods for surfactant removal from nanoparticle suspensions
09643148 ยท 2017-05-09
Assignee
Inventors
Cpc classification
B82Y40/00
PERFORMING OPERATIONS; TRANSPORTING
B01J13/0034
PERFORMING OPERATIONS; TRANSPORTING
International classification
B01J13/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
The present disclosure relates to the cleansing of nanoparticles in aqueous cationic surfactant solutions, including polyalkylammonium salts such as cetyltrimethylammonium bromide, as demonstrated by surfactant exchange, followed by the addition of peptizing agents to stabilize the cleansed nanoparticle solutes.
Claims
1. A method for converting CTAB-stabilized GNRs into citrate-stabilized GNRs, comprising: filtering excess surfactant from a GNR-CTAB suspension to result in a concentrated GNR-CTAB suspension; subjecting GNR-CTAB suspension to at least one centrifugation and redispersion cycle with solutions containing a mild detergent to deplete CTAB below trace levels, resulting in a CTAB-free GNR suspension; and subjecting CTAB-depleted GNR suspension to at least one centrifugation and redispersion cycle using sodium citrate solutions to produce suspensions of citrate-stabilized GNRs, devoid of detergent.
2. The method of claim 1, further comprising diluting the suspension of CTAB-stabilized GNRs to 25 mM CTAB.
3. The method of claim 1, further comprising filtering the suspension of CTAB-stabilized GNRs by stirred ultrafiltration.
4. The method of claim 1, wherein the mild detergent is sodium polystyrenesulfonate (Na-PSS).
5. The method of claim 4, the Na-PSS concentration being 0.15 wt %.
6. The method of claim 1, the diluted GNR-CTAB suspension being subject to three centrifugation and redispersion cycles with 0.15 wt % Na-PSS.
7. The method of claim 1, the CTAB-depleted GNR suspension being subjected to two centrifugation and redispersion cycles with aqueous sodium citrate.
8. The method of claim 1, the sodium citrate being at a concentration between 10 M and 10 mM.
9. The method of claim 1, the conversion of CTAB-GNRs into citrate-stabilized GNRs being 75% to 85%.
10. A method for removing cetyltrimethylammonium bromide (CTAB) from aqueous suspensions of gold nanorods (GNRs), comprising: intermediate treatment of a suspension of GNRs with sodium polystyrenesulfonate (Na-PSS) resulting in a treated GNR suspension; and subjecting the treated GNR suspension by further exchange with sodium citrate to produce citrate-stabilized GNRs (cit-GNRs).
11. A composition comprising citrate stabilized GNRs prepared by the method of claim 1.
12. A method of removing a cationic surfactant from a suspension of gold nanoparticles and preparing peptizing agent stabilized said gold nanoparticles, comprising: adding an anionic polymeric detergent to said suspension of gold nanoparticles to remove said cationic surfactant, resulting in a suspension depleted of said cationic surfactant to below detectable limit by X-ray photoelectron spectroscopy; and adding a peptizing agent to stabilize the cleansed gold nanoparticles, wherein said peptizing agent is selected from the group consisting of an anionic species, a zwitterion species, a nonionic species, and any combination thereof, and wherein said gold nanoparticles have hydrodynamic sizes between 1-200 nm.
13. A composition comprising peptizing agent stabilized GNRs, wherein the composition is essentially depleted CTAB or other cationic surfactant to below detectable limit by X-ray photoelectron spectroscopy.
14. The composition of claim 13, wherein the peptizing agent is selected from the group consisting of an anionic species, a zwitterionic species, a nonionic species, and any combination thereof.
15. The composition of claim 14, wherein the peptizing agent comprises citrate.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
DETAILED DESCRIPTION
(11) For the purposes of promoting an understanding of the principles of the present disclosure, reference will now be made to the embodiments illustrated in the drawings, and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of this disclosure is thereby intended.
(12) Referring to
EXAMPLE
(13) A six-stage protocol was developed to convert CTAB-GNRs (6826 nm, .sub.LPR=713 nm) into cit-GNRs, using standard ultrafiltration and centrifugation equipment. CTAB-GNRs were prepared on a gram scale by the method described by Khanal and Zubarev, then diluted with water to prevent premature flocculation of CTAB-GNRs during the initial purification stages. In a typical process, a suspension of GNRs (optical density (O.D.)=3.2) stabilized in 25 mM CTAB was concentrated to a few mL by stirred ultrafiltration to remove excess surfactant, then diluted with deionized water (Stage 1).
(14) Referring to
(15) The conversion of CTAB-GNRs into cit-GNRs was achieved with an overall efficiency of 75-85%, based on initial and final optical density (O.D.) values of the GNR dispersions at 713 nm. The main source of loss is due to incomplete recovery of GNRs during the first two C/R cycles. Absorption spectroscopy and TEM analysis of the citrate-stabilized GNRs indicated essentially no changes in optical absorption (
(16) The incubation of GNRs with Na-PSS (minimum 1 hour, prior to each C/R step) is essential for producing well-dispersed cit-GNRs. It is established that PSS adsorbs weakly onto GNR surfaces in the absence of CTAB, resulting in metastable dispersions whose relative stability depends on Na-PSS concentration, suggestive of depletion effects. Attempts to exchange CTAB directly with citrate invariably led to rapid aggregation, regardless of surfactant concentrations. For instance,
(17) The ligand exchange process from Stage 3 (PSS wash #2) to Stage 6 (citrate wash #2) was evaluated by XPS, based on the binding energies of various atomic species (Table 1 and
(18) TABLE-US-00001 TABLE 1 XPS analysis of GNR samples at different purification stages Stage bkgrnd.sup.b Stage bkgrnd.sup.b Stage 5.sup.a bkgrnd.sup.b Stage bkgrnd.sup.b Element 3.sup.a (PSS (PSS 4.sup.a (PSS (PSS (Cit. (Cit. 6.sup.a (Cit. (Cit. (B.E., eV)c #2) #2) #3) #3) #1) #1) #2) #2) C 1s (283) 210 93.8 205 67.6 8.00 9.27 6.44 1.04 N 1s (401) 1.51 1.28 0.03.sup.d 0.03.sup.d O 1s (530) 80.3 39.3 86.7 32.4 4.14 11.7 4.54 3.02 Na 1s 21.8 13.3 26.3 13.2 1.28 4.47 1.79 0.60 S 2p (167) 24.1 11.4 26.6 9.19 0.47 0.47 0.09 <0.03.sup.d Ag 3d 0.25 0.26 0.28 0.26 Si 2s (101) 1 1 1 1 Au 4f (82) 1 1 1 1 .sup.aSignals from pelleted GNR samples, normalized to Au 4f peak area. .sup.bSignals from supernatant of GNR samples, normalized to Si 2s peak area. .sup.cBinding energies from survey XPS spectra. .sup.dAt or below limit of detection.
(19) The ligand exchange process was characterized by ATR-IR spectroscopy and SERS, to identify the molecular species associated with the GNR samples (
(20) The herein disclosed method describes a general approach for depleting CTAB and other cationic surfactants from aqueous nanoparticle suspensions, allowing their clean exchange with various surface ligands. Specifically, an efficient method is disclosed for removing cationic surfactants such as cetyltrimethylammonium bromide (CTAB) from aqueous suspensions of nanoparticles using sodium polystyrenesulfonate (Na-PSS), followed by the addition of peptizing agents to stabilize the cleansed nanoparticle solutes, including but not limited to anionic species such as citrate and oxalate, zwitterionic species such as sulfobetaines and carboxybetaines, or nonionic species such as Tween-20. In the case of citrate-stabilized GNRs, the materials are compatible with conjugation chemistries commonly applied to most metal colloids, and are useful for evaluating changes in particle size as a function of ligand structure.
(21) Those skilled in the art will recognize that numerous modifications can be made to the specific implementations described above. The implementations should not be limited to the particular limitations described. Other implementations may be possible.
REFERENCES
(22) 1. Wei, A.; Leonov, A. P.; Wei, Q. S. Gold Nanorods: Multifunctional Agents for Cancer Imaging and Therapy. In Cancer Nanotechnology: Methods and Protocols, Grobmyer, S. R.; Moudgil, B. M., Eds. Humana Press Inc: Totowa, 2011; Vol. 624, pp 119-130. 2. Dreaden, E. C.; Alkilany, A. M.; Huang, X.; Murphy, C. J.; El-Sayed, M. A. The Golden Age: Gold Nanoparticles for Biomedicine. Chem. Soc. Rev. 2012, 41, 2740-2779. 3. Tong, L.; Wei, Q.; Wei, A.; Cheng, J.-X. Gold Nanorods as Contrast Agents for Biological Imaging: Surface Conjugation, Two-Photon Luminescence, and Photothermal Effects. Photochem. Photobiol. 2009, 85, 21-32. 4. Chou, C.-H.; Chen, C.-D.; Wang, C. R. C. Highly Efficient, Wavelength-Tunable, Gold Nanoparticle Based Optothermal Nanoconvertors. J. Phys. Chem. B 2005, 109, 11135-11138. 5. Yamashita, S.; Fukushima, H.; Niidome, Y.; Mori, T.; Katayama, Y.; Niidome, T. Controlled-Release System Mediated by a Retro Diels-Alder Reaction Induced by the Photothermal Effect of Gold Nanorods. Langmuir 2011, 27, 14621-14626. 6. Wijaya, A.; Schaffer, S. B.; Pallares, I. G.; Hamad-Schifferli, K. Selective Release of Multiple DNA Oligonucleotides from Gold Nanorods. ACS Nano 2009, 3, 80-86. 7. Kuo, T.-R.; Hovhannisyan, V. A.; Chao, Y.-C.; Chao, S.-L.; Chiang, S.-J.; Lin, S.-J.; Dong, C.-Y.; Chen, C.-C. Multiple Release Kinetics of Targeted Drug from Gold Nanorod Embedded Polyelectrolyte Conjugates Induced by near-Infrared Laser Irradiation. J. Am. Chem. Soc. 2010, 132, 14163-14171. 8. Dickerson, E. B.; Dreaden, E. C.; Huang, X.; El-Sayed, I. H.; Chu, H.; Pushpanketh, S.; McDonald, J. F.; El-Sayed, M. A. Gold Nanorod Assisted near-Infrared Plasmonic Photothermal Therapy (PPTT) of Squamous Cell Carcinoma in Mice Cancer Lett. 2008, 269, 57-66. 9. von Maltzahn, G.; Park, J.-H.; Agrawal, A.; Bandaru, N. K.; Das, S. K.; Sailor, M. J.; Bhatia, S. N. Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold Nanorod Antennas. Cancer Res. 2009, 69, 3892-3900. 10. Choi, W. I.; Kim, J.-Y.; Kang, C.; Byeon, C. C.; Kim, Y. H.; Tae, G. Tumor Regression in Vivo by Photothermal Therapy Based on Gold-Nanorod-Loaded, Functional Nanocarriers. ACS Nano 2011, 5, 1995-2003. 11. Mehtala, J. G.; Torregrosa-Allen, S.; Elzey, B. D.; Jeon, M.; Kim, C.; Wei, A. Synergistic Effects of Cisplatin Chemotherapy and Gold Nanorod-Mediated Hyperthermia on Ovarian Cancer Cells. Nanomedicine 2014, 9, in press (doi: 10.2217/nnm.13.209). 12. Huff, T. B.; Hansen, M. N.; Zhao, Y.; Cheng, J.-X.; Wei, A. Controlling the Cellular Uptake of Gold Nanorods. Langmuir 2007, 23, 1596-1599. 13. Alkilany, A. M.; Nagaria, P. K.; Hexel, C. R.; Shaw, T. J.; Murphy, C. J.; Wyatt, M. D. Cellular Uptake and Cytotoxicity of Gold Nanorods: Molecular Origin of Cytotoxicity and Surface Effects. Small 2009, 5, 701-708. 14. Liao, H.; Hafner, J. H. Gold Nanorod Bioconjugates. Chem. Mater 2005, 17, 4636-4641. 15. Kinnear, C.; Dietsch, H.; Clift, M. J. D.; Endes, C.; Rothen-Rutishauser, B.; Petri-Fink, A. Gold Nanorods: Controlling Their Surface Chemistry and Complete Detoxification by a Two-Step Place Exchange. Angew. Chem. Int. Ed. 2013, 52, 1934-1938. 16. Takahashi, H.; Niidome, Y.; Niidome, T.; Kaneko, K.; Kawasaki, H.; Yamada, H. Modification of Gold Nanorods Using Phosphatidylcholine to Reduce Cytotoxicity. Langmuir 2006, 22, 2-5. 17. Leonov, A. P.; Zheng, J.; Clogston, J. D.; Stern, S. T.; Patri, A. K.; Wei, A. Detoxification of Gold Nanorods by Treatment with Polystyrenesulfonate. ACS Nano 2008, 2, 2481-2488. 18. Indrasekara, A. S. D. S.; Wadams, R. C.; Fabris, L. Ligand Exchange on Gold Nanorods: Going Back to the Future. Part. Part. Syst. Charact. 2014, 31, in press. 19. Hayat, M. A. Colloidal Gold: Principles, Methods, and Applications. Academic Press: San Diego, 1989; Vol. 1. 20. Mehtala, J. G.; Wei, A. Nanometric Resolution in the Hydrodynamic Size Analysis of Ligand-Stabilized Gold Nanorods. Langmuir 2014, manuscript submitted. 21. Khanal, B. P.; Zubarev, E. R. Rings of Nanorods. Angew. Chem. Int. Ed. 2007, 46, 2195-2198. 22. Semchyschyn, D. J.; Carbone, M. A.; Macdonald, P. M. Anionic Polyelectrolyte Binding to Mixed Cationic-Zwitterionic Surfactant Micelles: A Molecular Perspective from .sup.2H NMR Spectroscopy. Langmuir 1996, 12, 253-260. 23. Napper, D. H. Polymer Stabilization of Colloid Dispersions. Academic: New York, 1983. 24. Takeda, S.-i.; Tobori, N.; Sugawara, H.; Furusawa, K. Dynamic Electrophoresis. In Electrical Phenomena at Interfaces: Fundamentals: Measurements, and Applications, 2nd ed.; Ohshima, H.; Furusawa, K., Eds. CRC Press: Boca Raton, 1998; pp 273-304. 25. Kawamura, G.; Yang, Y.; Nogami, M. End-to-End Assembly of CTAB-Stabilized Gold Nanorods by Citrate Anions. J. Phys. Chem. C 2008, 112, 10632-10636. 26. Nikoobakht, B.; El-Sayed, M. A. Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem. Mater 2003, 15, 1957-1962. 27. Sau, T. K.; Murphy, C. J. Seeded High Yield Synthesis of Short Au Nanorods in Aqueous Solution. Langmuir 2004, 20, 6414-6420. 28. Liu, M. Z.; Guyot-Sionnest, P. Mechanism of Silver(I)-Assisted Growth of Gold Nanorods and Bipyramids. J. Phys. Chem. B 2005, 109, 22192-22200. 29. Jackson, S. R.; McBride, J. R.; Rosenthal, S. J.; Wright, D. W. Where's the Silver? Imaging Trace Silver Coverage on the Surface of Gold Nanorods. J. Am. Chem. Soc. 2014, 136, 5261-5263. 30. Lin-Vien, D.; Colthup, N. B.; Fateley, W. G.; Grasselli, J. G. The Handbook of Infrared and Raman Characteristic Frequencies of Organic Molecules. 2nd ed.; Academic Press: San Diego, 1991.